Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Hypernatraemia (serum sodium > 145 mmol/L)

Nephrology · Abnormal laboratory result · updated 2026-11-08

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: 0.5 to 5% of inpatients [1]

> 155 mmol/L, impaired consciousness or patient unable to drink: refer

Detailed explanation and international comparison (in French): read it in English (machine translation)

146 to 155 mmol/L, conscious patient able to drink: tests

Laboratory tests

In the practice

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (6)
  1. Yun G, Baek SH, Kim S. Evaluation and management of hypernatremia in adults: clinical perspectives. Korean J Intern Med. 2023;38(3):290-302.
  2. Brennan M, Mulkerrin L, O'Keeffe ST, O'Shea PM. Approach to the management of hypernatraemia in older hospitalised patients. J Nutr Health Aging. 2021;25(10):1161-1166.
  3. Miller NE, Rushlow D, Stacey SK. Diagnosis and Management of Sodium Disorders: Hyponatremia and Hypernatremia. Am Fam Physician. 2023;108(5):476-486.
  4. Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and Management of Sodium Disorders: Hyponatremia and Hypernatremia. Am Fam Physician. 2015;91(5):299-307 (version corrigée ; remplacée en 2023 par l'article de Miller et al.).
  5. Working Group for Renaming Diabetes Insipidus. Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. Endocr Connect. 2022;11(11):e220378.
  6. ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit TÉRALITHE 250 mg (lithium), comprimé sécable, rubrique 4.8.